Aralez Pharmaceuticals Inc. (ARLZ): Andrew I Koven , President & Chief Business Off of Aralez Pharmaceuticals Inc. purchased 71,500 shares on May 12, 2016. The Insider buying transaction was reported by the company on May 13, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.49 per share for a total value of $249,470.66 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 7, 2016, Inc/bc Qlt (10% owner) sold 2,400,000 shares at $6.25 per share price.
Company has been under the radar of several Street Analysts. is Reiterated by Chardan Capital Markets to Buy while Lowering the Price Target of the company shares to $ 10 from a previous price target of $15.50 . The Rating was issued on Mar 16, 2016.